Chrissy Metz reveals she started weight loss medication after her father's death

Chrissy Metz, the 45-year-old actress known for her role on "This Is Us," has opened up about her decision to use a GLP-1 medication for weight loss, a choice she made following a personal tragedy. During appearances on "The Tamsen Show" podcast and the "Today" show, Metz detailed her journey and the criticism she faces regarding her body. She explained that she was initially skeptical and even afraid of GLP-1 medications, a class of drugs that has gained popularity for weight management. Her perspective shifted dramatically after her father passed away due to complications from obesity. This event served as a catalyst, making her realize that her weight struggles were not simply a matter of willpower but involved chemical, metabolic, and hereditary factors. She stated that the loss made her feel she had to take action.

Metz also addressed the relentless public scrutiny of her body, noting that criticism comes regardless of her size. She recounted a recent interaction with a distant relative who congratulated her for "taking control of your weight," a comment that, while not as hurtful as others, still highlighted the constant focus on her appearance. The actress expressed frustration that people feel entitled to comment on her body online in ways they would never do in person. She described the experience as "taxing" and "wild," emphasizing that no matter what she does—whether losing weight or not—someone will always have an opinion. This constant judgment, she noted, is a reality she has learned to shut off for her own well-being.

The decision to use medication was deeply personal and rooted in a new understanding of her health. Metz shared that before her father's death, she was unaware that her constant thoughts about food were not a universal experience. She realized that there was something "chemically off and metabolically off" that contributed to her condition. This revelation, combined with the hereditary aspect highlighted by her father's death, pushed her to seek a medical solution. Her story underscores a shift from viewing obesity as a personal failing to recognizing it as a complex medical issue that can require pharmaceutical intervention.

The broader context of Metz's revelation touches on the ongoing public debate surrounding weight loss drugs and body image. By sharing her story, she contributes to a growing conversation about the medicalization of obesity and the stigma attached to using medication for weight management. Her experience illustrates the emotional toll of public fat-shaming and the personal, often painful, motivations behind an individual's health choices. The actress's candidness provides insight into the pressures faced by public figures and the complex, multifaceted reasons someone might choose a medical path to weight loss, challenging simplistic narratives about diet and exercise.